(S (NP (NP (DT The) (NN complexity)) (PP (IN of) (NP (JJ human) (NN cancer)))) (ADVP (RB often)) (VP (VBZ results) (PP (IN in) (NP (NP (JJ significant) (NN heterogeneity)) (PP (IN in) (NP (NN response))))) (PP (IN to) (NP (NN treatment)))) (. .))
(S (NP (NNP Precision) (NN medicine)) (VP (VBZ offers) (ADJP (JJ potential) (S (VP (TO to) (VP (VB improve) (NP (JJ patient) (NNS outcomes)) (PP (IN by) (S (VP (VBG leveraging) (NP (DT this) (NN heterogeneity)))))))))) (. .))
(S (NP (NP (JJ Individualized) (NN treatment) (NNS rules)) (-LRB- -LRB-) (NP (NNS ITRs)) (-RRB- -RRB-)) (VP (VBP formalize) (NP (NP (NN precision) (NN medicine)) (PP (IN as) (NP (NP (NNS maps)) (PP (IN from) (NP (DT the) (JJ patient) (NN covariate) (NN space)))))) (PP (IN into) (NP (NP (DT the) (NN space)) (PP (IN of) (NP (JJ allowable) (NNS treatments)))))) (. .))
(S (NP (DT The) (JJ optimal) (NN ITR)) (VP (VBZ is) (NP (NP (DT that)) (SBAR (WHNP (WDT which)) (S (VP (VBZ maximizes) (NP (NP (DT the) (NN mean)) (PP (IN of) (NP (NP (DT a) (JJ clinical) (NN outcome)) (PP (IN in) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (NN interest))))))))))))) (. .))
(S (NP (NML (NN Patient) (HYPH -) (NML (NML (VBN derived) (NN xenograft)) (-LRB- -LRB-) (NML (NN PDX)) (-RRB- -RRB-))) (NNS studies)) (VP (VP (VBP permit) (NP (NP (DT the) (NN evaluation)) (PP (IN of) (NP (JJ multiple) (NNS treatments)))) (PP (IN within) (NP (DT a) (JJ single) (NN tumor)))) (CC and) (ADVP (RB thus)) (VP (VBP are) (ADVP (RB ideally)) (VP (VBN suited) (PP (IN for) (S (VP (VBG estimating) (NP (JJ optimal) (NNS ITRs)))))))) (. .))
(S (NP (NN PDX) (NNS data)) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (NP (VBN correlated) (NNS outcomes)) (, ,) (NP (NP (DT a) (ADJP (JJ high) (HYPH -) (JJ dimensional)) (NN feature) (NN space)) (, ,) (CC and) (NP (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (NNS treatments))))))))) (. .))
(S (NP (NP (VBG Existing) (NNS methods)) (PP (IN for) (S (VP (VBG estimating) (NP (JJ optimal) (NNS ITRs)))))) (VP (VBP do) (RB not) (VP (VP (VB take) (NP (NP (NN advantage)) (PP (IN of) (NP (NP (DT the) (JJ unique) (NN structure)) (PP (IN of) (NP (NN PDX) (NNS data))))))) (CC or) (VP (VB handle) (NP (DT the) (JJ associated) (NNS challenges)) (ADVP (RB well))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP explore) (NP (NML (NN machine) (NN learning)) (NNS methods)) (PP (IN for) (S (VP (VBG estimating) (NP (JJ optimal) (NNS ITRs)) (PP (IN from) (NP (NNP PDX) (NNS data))))))) (. .))
(S (NP (PRP We)) (VP (VBP analyze) (NP (NNS data)) (PP (IN from) (NP (DT a) (JJ large) (NN PDX) (NN study))) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS biomarkers)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ informative) (PP (IN for) (S (VP (VBG developing) (NP (JJ personalized) (NN treatment) (NNS recommendations)) (PP (IN in) (NP (JJ multiple) (NNS cancers))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP estimate) (NP (JJ optimal) (NNS ITRs)) (S (VP (VBG using) (NP (NP (ADJP (NP (NN regression)) (HYPH -) (VBN based)) (NNS approaches)) (PP (JJ such) (IN as) (NP (NML (NML (NN Q) (HYPH -) (NN learning)) (CC and) (NML (JJ direct) (NN search))) (NNS methods))) (PP (JJ such) (IN as) (NP (NP (NN outcome)) (VP (VBN weighted) (NP (NN learning))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VP (VBP implement) (NP (DT a) (NN superlearner) (NN approach)) (S (VP (TO to) (VP (VB combine) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (VBN estimated) (NNS ITRs)))))))) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (VBG resulting) (NNP ITR)) (VP (VBZ performs) (NP (NP (ADJP (ADJP (JJR better) (PP (IN than) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN input) (NNS ITRs)))))) (, ,) (ADJP (JJ mitigating))) (NN uncertainty)) (PP (VBG regarding) (NP (NP (NN user) (NN choice)) (PP (IN of) (NP (DT any) (JJ particular) (NNP ITR) (NN estimation) (NN methodology))))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN PDX) (NNS data)) (VP (VBP are) (NP (NP (DT a) (JJ valuable) (NN resource)) (PP (IN for) (S (VP (VBG developing) (NP (ADJP (JJ individualized)) (NN treatment) (NNS strategies)) (PP (IN in) (NP (NN oncology))))))))))) (. .))
